Sweden Removes Dronabinol and Cannabidiol Preparations from National Reimbursement
The decision may disrupt established treatment for approximately 2,000 patients and raises questions about continuity of care, clinical equivalence and equitable access. 25 August 2026 | News analysis Sweden’s Dental and Pharmaceutical Benefits Agency (Tandvards- och lakemedelsformansverket, TLV) has decided that extemporaneously prepared oral medicines containing dronabinol or cannabidiol will be excluded from the national … […]